Drug Shortage Report for BRETYLIUM TOSYLATE INJECTION USP
| Report ID | 18340 |
| Drug Identification Number | 02185377 |
| Brand name | BRETYLIUM TOSYLATE INJECTION USP |
| Common or Proper name | BRETYLIUM |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | BRETYLIUM TOSYLATE |
| Strength(s) | 50MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 5 X 10ML VIALS |
| ATC code | C01BD |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2018-08-01 |
| Estimated end date | Unknown |
| Actual end date | 2021-04-21 |
| Shortage status | Resolved |
| Updated date | 2023-11-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-11-17 | French | Compare |
| v7 | 2023-11-17 | English | Compare |
| v6 | 2017-12-04 | French | Compare |
| v5 | 2017-12-04 | English | Compare |
| v4 | 2017-10-18 | French | Compare |
| v3 | 2017-10-18 | English | Compare |
| v2 | 2017-08-07 | French | Compare |
| v1 | 2017-08-07 | English | Compare |
Showing 1 to 8 of 8